PL427326A1 - Radiosensybilizator w postaci 5-jodo-4-tio-2'-deoksyurydyny do zastosowania w radioterapii <!--[if gte mso 9]><xml> <o:OfficeDocumentSettings> <o:RelyOnVML/> <o:AllowPNG/> </o:OfficeDocumentSettings> </xml><![endif]--> - Google Patents

Radiosensybilizator w postaci 5-jodo-4-tio-2'-deoksyurydyny do zastosowania w radioterapii <!--[if gte mso 9]><xml> <o:OfficeDocumentSettings> <o:RelyOnVML/> <o:AllowPNG/> </o:OfficeDocumentSettings> </xml><![endif]-->

Info

Publication number
PL427326A1
PL427326A1 PL427326A PL42732618A PL427326A1 PL 427326 A1 PL427326 A1 PL 427326A1 PL 427326 A PL427326 A PL 427326A PL 42732618 A PL42732618 A PL 42732618A PL 427326 A1 PL427326 A1 PL 427326A1
Authority
PL
Poland
Prior art keywords
radiosensitizer
deoxyuridine
radiotherapy
iodo
thio
Prior art date
Application number
PL427326A
Other languages
English (en)
Other versions
PL236657B1 (pl
Inventor
Witold Kozak
Janusz Rak
Samanta Romanowska
Paulina Spisz
Magdalena Zdrowowicz
Original Assignee
Uniwersytet Gdański
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Gdański filed Critical Uniwersytet Gdański
Priority to PL427326A priority Critical patent/PL236657B1/pl
Priority to EP19200633.6A priority patent/EP3632468B1/en
Publication of PL427326A1 publication Critical patent/PL427326A1/pl
Publication of PL236657B1 publication Critical patent/PL236657B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Przedmiotem zgłoszenia jest 5-jodo-4-tio-2'-deoksyurydyna do zastosowania w radioterapii jako radiosensybilizator, zwiększający efektywność działania promieniowania wobec komórek nowotworowych.
PL427326A 2018-10-02 2018-10-02 Radiosensybilizator do zastosowania w radioterapii PL236657B1 (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL427326A PL236657B1 (pl) 2018-10-02 2018-10-02 Radiosensybilizator do zastosowania w radioterapii
EP19200633.6A EP3632468B1 (en) 2018-10-02 2019-09-30 5-iodo-4-thio-2'-deoxyuridine for use as a radiosensitizer in radiotherapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL427326A PL236657B1 (pl) 2018-10-02 2018-10-02 Radiosensybilizator do zastosowania w radioterapii

Publications (2)

Publication Number Publication Date
PL427326A1 true PL427326A1 (pl) 2020-04-06
PL236657B1 PL236657B1 (pl) 2021-02-08

Family

ID=68502794

Family Applications (1)

Application Number Title Priority Date Filing Date
PL427326A PL236657B1 (pl) 2018-10-02 2018-10-02 Radiosensybilizator do zastosowania w radioterapii

Country Status (2)

Country Link
EP (1) EP3632468B1 (pl)
PL (1) PL236657B1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL448242A1 (pl) * 2024-04-09 2025-10-13 Uniwersytet Gdański Pochodna 2'-deoksyadenozyny w postaci 8-benzylo(4-trifluorometoksy)-2'-deoksyadenozyny, sposób jej otrzymywania oraz jej zastosowanie jako radiosensybilizator

Also Published As

Publication number Publication date
PL236657B1 (pl) 2021-02-08
EP3632468A1 (en) 2020-04-08
EP3632468B1 (en) 2023-12-13

Similar Documents

Publication Publication Date Title
CO2019007298A2 (es) Inhibidores de tgfβ1 isoforma-específicos contexto-permisivos y uso de los mismos
MX2020012797A (es) Anticuerpos biespecificos anti-pvrig/anti-tigit y métodos de uso.
MX2021006681A (es) Anticuerpos anti-claudina y usos de los mismos.
JOP20180039A1 (ar) مثبطات pd-1/pd-l1
MY196582A (en) PD-1/PD-L1 Inhibitors
CY1122522T1 (el) Μετα αρσενικωδες νατριο για χρηση στην αγωγη του πολλαπλου μυελωματος
EP4527922A3 (en) Human leukocyte antigen restricted gamma delta t cell receptors and methods of use thereof
GEAP202215479A (en) Magl inhibitors
MX2020009861A (es) Anticuerpos contra el complejo principal de histocompatibilidad relacionado con las cadenas a y b clase i (mica) y/o (micb) y sus usos.
BR112015026297A2 (pt) terapia combinada composta por um inibidor tor quinase e um composto de 5-quinazolinona substituído para o tratamento de câncer
MX2016006726A (es) Composiciones que comprenden anticuerpos anti-molecula de adhesion celular relacionada con antigeno carcinoembrionario 1 y anti-muerte celular programada para la terapia contra el cancer.
MX2020010412A (es) Inhibidores de tirosina quinasa de bruton.
MX2022006073A (es) Metodos para utilizar anticuerpos anti-trem2.
EA202191557A1 (ru) Комбинированная терапия радиоиммуноконъюгатами и ингибиторами репарации повреждений днк
PH12021551036A1 (en) Anti-liv1 immune cell cancer therapy
EA201991622A1 (ru) Комплексная терапия для лечения рака
TN2019000210A1 (en) Antitumoral compounds
PH12020551543A1 (en) Therapeutic modulators of the reverse mode of atp synthase
BR112015026247A2 (pt) métodos para o tratamento de câncer com o uso de terapia combinada com inibidor de cinase tor
MX388026B (es) Compuestos y métodos para modular la tirosina cinasa de bruton.
MX2019011116A (es) Inhibidores de la tirosina quinasa de bruton.
MX2021013354A (es) Metodos para tratar y/o prevenir queratosis actinica.
MX2023010501A (es) Profarmacos de dantroleno y metodos de su uso.
MX2020001727A (es) Terapia de combinacion.
MX2019009356A (es) Sulfinilpiridinas y su uso en el tratamiento del cancer.